Mainz Biomed Bv Stock Analysis

Mainz Stock Analysis Notes

About 20.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.72. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mainz Biomed BV recorded a loss per share of 1.11. The entity had not issued any dividends in recent years. Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic and research use only tests for clinical diagnostics in human genetics. The company was founded in 2008 and is based in Mainz, Germany. Mainz Biomed is traded on NASDAQ Exchange in the United States. To find out more about Mainz Biomed BV contact Guido Baechler at 49 6131 554 2860 or learn more at https://mainzbiomed.com.

Mainz Biomed BV Investment Alerts

Mainz Biomed BV Upcoming and Recent Events

Mainz Largest EPS Surprises

View All Earnings Estimates

Mainz Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.39 M.

Mainz Profitablity

Management Efficiency

Mainz Biomed BV has return on total asset (ROA) of (0.9924) % which means that it has lost $0.9924 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (43.3371) %, meaning that it created substantial loss on money invested by shareholders. Mainz Biomed's management efficiency ratios could be used to measure how well Mainz Biomed manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.3 in 2024. Return On Capital Employed is likely to rise to -4.1 in 2024. At this time, Mainz Biomed's Non Current Assets Total are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 7.7 M in 2024, whereas Total Assets are likely to drop slightly above 10.4 M in 2024.

Technical Drivers

As of the 30th of November, Mainz Biomed secures the Mean Deviation of 6.19, risk adjusted performance of (0.02), and Standard Deviation of 8.77. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mainz Biomed BV, as well as the relationship between them.

Mainz Biomed BV Price Movement Analysis

Mainz Biomed Outstanding Bonds

Mainz Biomed Predictive Daily Indicators

Mainz Biomed Forecast Models

Mainz Biomed's time-series forecasting models are one of many Mainz Biomed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mainz Biomed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mainz Biomed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mainz shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mainz Biomed. By using and applying Mainz Stock analysis, traders can create a robust methodology for identifying Mainz entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mainz analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mainz analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Mainz Biomed BV stock analysis indicators help investors evaluate how Mainz Biomed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mainz Biomed shares will generate the highest return on investment. By understating and applying Mainz Biomed stock analysis, traders can identify Mainz Biomed position entry and exit signals to maximize returns.

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.